MP-376 (Levofloxacin solution for Inhalation)

DRUG4 trials

Sponsors

Amgen

Conditions

Chronic Obstructive Pulmonary DiseaseCystic Fibrosis

Phase 1

Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic Fibrosis

CompletedNCT00503490

AmgenCystic Fibrosis

Start: 2007-06-30End: 2007-12-31Updated: 2024-12-04

A Phase 1b Study to Evaluate the Safety and PK of MP-376 in Chronic Obstructive Pulmonary Disease (COPD) Patients

CompletedNCT00752414

AmgenChronic Obstructive Pulmonary Disease

Start: 2008-07-31End: 2008-10-31Updated: 2024-12-04

Safety, Tolerability and Pharmacokinetics of MP-376 Administered for 14 Days to Stable Pediatric (CF) Patients

CompletedNCT00840333

AmgenCystic Fibrosis

Start: 2009-04-30End: 2009-12-31Updated: 2024-12-04

Phase 3

Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients

CompletedNCT01270347

AmgenCystic Fibrosis

Start: 2011-01-31End: 2013-06-30Updated: 2024-12-13